Making Science Group, S.A. (BME:MAKS)
Spain · Delayed Price · Currency is EUR 7.50
0.00 (0.00%)
Jun 5, 2026, 5:35 PM CET
Making Science Group Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 348.29 | 271.32 | 235.77 | 210.13 | 112.9 | |
Revenue Growth (YoY) | 28.37% | 15.08% | 12.20% | 86.12% | 91.77% |
Cost of Revenue | 326.12 | 246.63 | 214.71 | 188.55 | 101.71 |
Gross Profit | 22.17 | 24.7 | 21.05 | 21.58 | 11.19 |
Selling, General & Admin | - | - | - | - | 9.26 |
Other Operating Expenses | 14.8 | 14.93 | 13.4 | 14.05 | -0.07 |
Operating Expenses | 21.98 | 21.01 | 20.33 | 18.06 | 13.01 |
Operating Income | 0.19 | 3.68 | 0.72 | 3.52 | -1.82 |
Interest Expense | -4.29 | -5.32 | -4.9 | -2.09 | -0.79 |
Interest & Investment Income | 0.26 | 1.11 | 0.34 | 0.05 | - |
Earnings From Equity Investments | - | - | -0 | 0 | 0.01 |
Currency Exchange Gain (Loss) | -0.18 | -0.92 | 0.43 | -1.13 | -0.3 |
Other Non Operating Income (Expenses) | - | - | - | - | 0.03 |
EBT Excluding Unusual Items | -4.02 | -1.45 | -3.41 | 0.35 | -2.87 |
Impairment of Goodwill | -2.53 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.02 |
Asset Writedown | -0.13 | - | - | - | - |
Other Unusual Items | - | - | - | 0.62 | 0.35 |
Pretax Income | -6.68 | -1.45 | -3.41 | 0.97 | -2.54 |
Income Tax Expense | 0.91 | 0.77 | 0.71 | 1.48 | 0.66 |
Earnings From Continuing Operations | -7.59 | -2.22 | -4.12 | -0.51 | -3.2 |
Earnings From Discontinued Operations | 32.6 | 0.78 | - | - | - |
Net Income to Company | 25.01 | -1.44 | -4.12 | -0.51 | -3.2 |
Minority Interest in Earnings | -0.18 | -0.28 | 0.02 | -0.39 | -0.29 |
Net Income | 24.83 | -1.72 | -4.09 | -0.91 | -3.49 |
Net Income to Common | 24.83 | -1.72 | -4.09 | -0.91 | -3.49 |
Shares Outstanding (Basic) | 9 | 9 | 8 | 8 | 8 |
Shares Outstanding (Diluted) | 9 | 9 | 8 | 8 | 8 |
Shares Change (YoY) | 1.27% | 3.85% | 3.10% | 7.19% | 11.54% |
EPS (Basic) | 2.83 | -0.20 | -0.49 | -0.11 | -0.46 |
EPS (Diluted) | 2.83 | -0.20 | -0.49 | -0.11 | -0.46 |
Free Cash Flow | 38.38 | 0.05 | -1.49 | 10.56 | 6.54 |
Free Cash Flow Per Share | 4.37 | 0.01 | -0.18 | 1.30 | 0.86 |
Dividend Per Share | 0.222 | - | - | - | - |
Gross Margin | 6.37% | 9.10% | 8.93% | 10.27% | 9.92% |
Operating Margin | 0.05% | 1.36% | 0.31% | 1.68% | -1.61% |
Profit Margin | 7.13% | -0.63% | -1.74% | -0.43% | -3.09% |
Free Cash Flow Margin | 11.02% | 0.02% | -0.63% | 5.03% | 5.79% |
EBITDA | 0.91 | 4.23 | 1.41 | 4.02 | 1.22 |
EBITDA Margin | 0.26% | 1.56% | 0.60% | 1.91% | 1.08% |
D&A For EBITDA | 0.72 | 0.55 | 0.69 | 0.5 | 3.04 |
EBIT | 0.19 | 3.68 | 0.72 | 3.52 | -1.82 |
EBIT Margin | 0.05% | 1.36% | 0.31% | 1.68% | -1.61% |
Effective Tax Rate | - | - | - | 152.93% | - |